centogene-get-in-touch-contact-us-header-01.jpg

Crown LiquidationCo N.V. Files Liquidation Accounts and Plan of Distribution

Crown LiquidationCo N.V. in liquidatie (formerly Centogene N.V.) (the “Company”) announces that the Liquidation Accounts and Plan of Distribution (the “Liquidation Plan”) have been finalized and filed with the Dutch Trade Register (Kamer van Koophandel) on August 7, 2026, which filing was announced in accordance with Dutch lawon August 8, 2026.

The Liquidator will continue to progress the remaining liquidation activities as outlined in the Liquidation Plan.

Subject to completion of the remaining liquidation activities, the Liquidator intends to proceed with a final liquidation distribution of remaining liquidation proceeds (if any) (the “Second Distribution”) as contemplated by the Liquidation Plan.

The Company will provide a further update on the investor website regarding the Second Distribution (if any), including the applicable record date and payment date, once determined.

Download Liquidation Plan

Disclaimers

Investors are encouraged to read carefully and in their entirety the materials made publicly available in connection with the Extraordinary General Meeting held on December 4, 2024 and the form 6-k filed on November 13, 2024, as they contain important information about the Company, the Company’s liquidation and related matters.

This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in the Company. This announcement is not for release, publication, or distribution, in whole or in part, in or into, directly or indirectly, in any jurisdiction in which such release, publication or distribution would be unlawful.

Forward-Looking Statements

This announcement contains “forward-looking statements” within the meaning of the U.S. federal securities laws. Statements contained herein that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “continues,” “expect,” “estimate,” “intend,” “project,” “plan,” “is designed to,” “potential,” “predict,” “objective” and similar expressions and future or conditional verbs such as “will,” “would,” “should,” “could,” “might,” “can,” and “may,” or the negative of these are generally intended to identify forward-looking statements. Forward-looking statements may include statements regarding the amount of funds (if any) from the Transaction available to pay to the Company’s stockholders in a liquidation distribution, the Company’s plans to dissolve, liquidate and suspend its reporting obligations under the U.S. securities laws, and any assumptions underlying any of the foregoing. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause the Company’s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward- looking statements. Such risks and uncertainties include, among others, (i) the outcome of any legal proceedings related to the Transaction, the dissolution and liquidation of the Company or its subsidiaries or otherwise, (ii) economic, business and/or competitive factors that may adversely affect the Company,  (iii) negative economic and geopolitical conditions and instability and volatility in the worldwide financial markets, (iv) possible changes in current and proposed legislation, regulations and governmental policies, (v) the Company’s ability to streamline cash usage and (vi) the Company’s continued ongoing compliance with covenants linked to financial instruments. Any forward-looking statements contained in this announcement speak only as of the date hereof.

Further Information About the Transaction and Liquidation

U.S. Securities and Exchange Commission Archive
Convening notice with explanatory notes – EGM 2024.pdf
Announcement – Crown LiquidationCo N.V. in liquidatie Announces Cessation of Trading on OTC Market and Advance Liquidation Distribution.pdf

Contact

Investor.relations@centogene.com